CITIC Securities: The PDRN industry chain is expected to see significant development, and we are optimistic about companies with a leading position in the PDRN aesthetic medical products sector.

CITIC Securities stated that ingredient innovation is an important driving force for the growth of the skincare and medical beauty sectors. Following hyaluronic acid and collagen, the industry is in urgent need of blockbuster ingredients to lead the way. We believe PDRN has the potential to become a bestseller: its efficacy has been fully demonstrated, it has established a strong consumer recognition base, it has long-term application verification and consumer acceptance in overseas medical beauty and skincare products.